Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diamyd in LADA
NCT00456027Phase 2Completed
- Sponsor
- Diamyd Medical
- Start
- Dec 2004
- Primary completion
- Mar 2008
- Modality
- Recombinant Proteins and Enzymes, Subcutaneous Immunotherapy, Sublingual Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of Diamyd in latent autoimmune diabetes in adults (LADA), sponsored by Diamyd Medical. Started Dec 2004; status: completed.
02
Drugs
Diamyd
03
Conditions
latent autoimmune diabetes in adults (LADA)
Beyond the preview
Go deeper on NCT00456027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00456027.